Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation
Open Access
- 1 May 2008
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 22 (8) , 2949-2956
Abstract
Transplantation of Bcl‐2‐transduced human umbilical vein endothelial cells (ECs) in protein gels into the gastrocnemius muscle improves local reperfusion in immunodeficient mouse hosts with induced hind limb ischemia. We tested the hypothesis that incorporation of local, sustained growth factor delivery could enhance and accelerate this effect. Tissue engineering scaffolds often use synthetic polymers to enable controlled release of proteins, but most synthetic delivery systems have major limitations, most notably hydrophobicity and inefficient protein loading. Here, we report the development of a novel alginate‐based delivery system for vascular endothelial growth factor‐A 165 (VEGF) that exhibits superior loading efficiency and physical properties to previous systems in vitro. In vivo , VEGF released from alginate microparticles within protein gels was biologically active and, when combined with EC transplantation, led to increased survival of transplanted cells at 28 days. The composite graft described also improved early (14 days) tissue perfusion and late (28 days) muscle myoglobin expression, a sign of recovery from ischemia, compared with EC transplantation and VEGF delivery separately. We conclude that our improved approach to sustained VEGF delivery in tissue engineering is useful in vivo and that the integration of high efficiency protein delivery enhances the therapeutic effect of protein gel‐based EC transplantation.—Jay, S. M., Shepherd, B. R., Bertram, J. P., Pober, J. S., Saltzman, W. M. Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J. 22, 2949–2956 (2008)Keywords
Funding Information
- National Institutes of Health (R01‐HL‐085416‐01)
This publication has 43 references indexed in Scilit:
- Polyelectrolyte Complexes Stabilize and Controllably Release Vascular Endothelial Growth FactorBiomacromolecules, 2007
- Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesisJournal of Thrombosis and Haemostasis, 2007
- Impact of Cell Type and Density on Nerve Growth Factor Distribution and Bioactivity in 3-Dimensional Collagen Gel CulturesTissue Engineering, 2006
- Regulating activation of transplanted cells controls tissue regenerationProceedings of the National Academy of Sciences, 2006
- Delivery of Hepatotrophic Factors Fails to Enhance Longer-Term Survival of Subcutaneously Transplanted HepatocytesTissue Engineering, 2006
- Extensive In Vivo Angiogenesis Following Controlled Release of Human Vascular Endothelial Cell Growth Factor: Implications for Tissue Engineering and Wound HealingArtificial Organs, 2001
- Biomedical applications of collagenInternational Journal of Pharmaceutics, 2001
- Development of poly-(d,l-lactide–coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesisJournal of Controlled Release, 2001
- Simultaneous delivery of an active protein and neutralizing antibody: creation of separated regions of biological activityJournal of Controlled Release, 2001
- Development andin vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction techniqueJournal of Biomedical Materials Research, 2000